OpenVSafe by OpenVAERS
Search V-safe

KG8-29104-21026

2 vaccinations 2 coded responses 10 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
201 / VA
Registered
2021-02-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-12
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-13
    Registered in v-safe
  3. 2021-02-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-02-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-02-26
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  6. 2021-03-01
    Dose 2 — Pfizer-BioNTech
  7. 2021-03-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-03-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  9. 2021-03-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-03-15
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-04-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-12
    Survey response — day 42, dose 2
    MedDRA: Placental calcification, Pregnancy — Feeling: Good
    Free text: Calcified placenta at 36 weeks gestation.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-31
    Survey response — 3 months, dose 2
    MedDRA: Pregnancy, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Early placental calcifications noticed on ultrasound at 36 weeks gestation. Healthy pregnancy otherwise, No other risk factors (No history of GDM, HTN, etc). · Healthcare visit (other): Maternal fetal medicine weekly NSTs for baby. Delivery at 38 weeks.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-31
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-06-03
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-02-12Pfizer-BioNTech
22021-03-01Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 7 — day 42, dose 2

2021-04-12

Symptoms: Calcified placenta at 36 weeks gestation.

Release 8 — 3 months, dose 2

2021-05-31

Symptoms: Early placental calcifications noticed on ultrasound at 36 weeks gestation. Healthy pregnancy otherwise, No other risk factors (No history of GDM, HTN, etc).
Healthcare visit (other): Maternal fetal medicine weekly NSTs for baby. Delivery at 38 weeks.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDPlacental calcification ✓ ✓ ✓
SDPregnancy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release